Quality-adjusted time without symptoms of disease or toxicity (Q-TWiST) in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a comparison of ponatinib versus imatinib - Ashaye, Ajibade; Shi, Ling; Aldoss, Ibrahim; Montesinos, Pau; Vachhani, Pankit; Rocha, Vanderson Geraldo; Papayannidis, Cristina; Leonard, Jessica T; Baer, Maria R; Ribera, Jose-Maria (Cancer medicine, 2025)